Court sanctions Takeda’s acquisition of Shire — 3 insights

The Royal Court of Jersey sanctioned Shire’s proposed acquisition of Takeda Pharmaceuticals.

Advertisement

Here’s what you should know:

1. Takeda will close its acquisition Jan. 8.

2. Takeda is purchasing Shire for $62 billion.

3. The acquisition will make Takeda one of the world’s most indebted pharmaceutical companies.

More articles on gastroenterology:
CRH Medical acquires Anesthesia Care Associates — 4 insights
5 insights into 2019 American Academy of Ophthalmology President Dr. George Williams
$15K raised for ASC employees devastated by California wildfires — 3 insights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.